Close
American Drug Delivery & Formulation Summit

Harmonix introduces non-prescription sleep aid

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

The World Health Organization (WHO) has officially launched the...
- Advertisement -

Harmonix has introduced Sleep Formula 39 to overcome sleep problems and to provide a better night’s sleep.

Sleep Formula 39 is a non-prescription sleep aid made up with a proprietary combination of sleep ingredients including 5-HTP, melatonin, GABA and L-Tryptophan which facilitates to improve the onset, quality and duration of sleep.

The product is available in twin packs of 2 oz. single serving bottles available at all metro Atlanta area CVS or pharmacy stores, select local GNC and Rite Aid stores.Sleep Formula 39 contain no drugs, no antihistamines, no hangover effect, no sugar, salt or carbohydrates and it is not habit forming.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

The World Health Organization (WHO) has officially launched the...

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป